Short Communication

Steroid-sparing effect of mycophenolate mofetil in the treatment of a subepidermal blistering autoimmune disease in a dog : clinical communication

P.J. Ginel, B. Blanco, R. Lucena, C.R. Jimenez, C. Peinado-Guitart, E. Mozos
Journal of the South African Veterinary Association | Vol 81, No 4 | a157 | DOI: https://doi.org/10.4102/jsava.v81i4.157 | © 2010 P.J. Ginel, B. Blanco, R. Lucena, C.R. Jimenez, C. Peinado-Guitart, E. Mozos | This work is licensed under CC Attribution 4.0
Submitted: 21 May 2010 | Published: 21 May 2010

About the author(s)

P.J. Ginel,
B. Blanco,
R. Lucena,
C.R. Jimenez,
C. Peinado-Guitart,
E. Mozos,

Full Text:

PDF (816KB)

Abstract

A 7-year-old female Cocker spaniel-cross was referred with an 8-month history of mucocutaneous erosive dermatitis. On physical examination, skin lesions affected the eyelids and periocular area, lips and vulva. Lesions were symmetrical with small diffuse superficial ulcers, haemorrhagic crusts, adherent purulent exudation in haired skin, and alopecia with hyperpigmentation and scarring. Histopathologic evaluation showed multiple, non-intact dermoepidermal junction vesicles and ulceration associated with a dermal lichenoid infiltrate. Immunohistochemistry showed strong to moderate reactivity in the dermoepidermal junction for the antibodies directed against canine IgG, human IgG lambda light chains and C3, respectively. A diagnosis of autoimmune subepidermal blistering dermatosis was made. Treatment with oral prednisone at 2 mg/kg and mycophenolate mofetil (MMF) at 20 mg/kg twice daily was initiated and after 4 weeks the ulcers and erosions were cured. During the rest of treatment, MMF was maintained at 10 mg/kg twice daily and prednisone could be tapered to 0.25 mg/kg once every other day without recurrences. In conclusion, this case report shows that MMF was well tolerated and might be effective as steroid-sparing agent in the long-term treatment of this autoimmune subepidermal blistering disease.

Keywords

blistering dermatosis; canine; mycophenolate mofetil

Metrics

Total abstract views: 4216
Total article views: 3826

 

Crossref Citations

1. Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus
Jae-Eun Hyun, Yeong-Hun Kang, Cheol-Yong Hwang
Veterinary Sciences  vol: 8  issue: 5  first page: 72  year: 2021  
doi: 10.3390/vetsci8050072

2. Treatment of moderate‐to‐severe canine atopic dermatitis with modified‐release mycophenolate (OKV‐1001): A pilot open‐label, single‐arm multicentric clinical trial
Michael Klotsman, Wayne H. Anderson, Danielle Wyatt, Tom Lewis, Natalie Theus, Domenico Santoro
Veterinary Dermatology  vol: 35  issue: 6  first page: 652  year: 2024  
doi: 10.1111/vde.13283

3. Use of mycophenolate mofetil to treat immune‐mediated skin disease in 14 dogs – a retrospective evaluation
Amanda L. Ackermann, Elizabeth R. May, Linda A. Frank
Veterinary Dermatology  vol: 28  issue: 2  first page: 195  year: 2017  
doi: 10.1111/vde.12400

4. Treatment of canine idiopathic immune‐mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011)
A. Wang, J. R. Smith, K. E. Creevy
Journal of Small Animal Practice  vol: 54  issue: 8  first page: 399  year: 2013  
doi: 10.1111/jsap.12107

5. Mycophenolic acid in patients with immune‐mediated inflammatory diseases: From humans to dogs
Michael Klotsman, Gayatri Sathyan, Wayne H. Anderson, Oliver A. Garden, Padmaja Shivanand
Journal of Veterinary Pharmacology and Therapeutics  vol: 42  issue: 2  first page: 127  year: 2019  
doi: 10.1111/jvp.12731

6. Treatment of presumptive primary immune‐mediated thrombocytopenia with mycophenolate mofetil versus cyclosporine in dogs
F. O. Cummings, S. A. Rizzo
Journal of Small Animal Practice  vol: 58  issue: 2  first page: 96  year: 2017  
doi: 10.1111/jsap.12621

7. Glucocorticoids, Cyclosporine, Azathioprine, Chlorambucil, and Mycophenolate in Dogs and Cats
Katrina R. Viviano
Veterinary Clinics of North America: Small Animal Practice  vol: 52  issue: 3  first page: 797  year: 2022  
doi: 10.1016/j.cvsm.2022.01.009

8. Pharmacology of drugs used in autoimmune dermatopathies in cats and dogs: A narrative review
Heng L. Tham, Jennifer L. Davis
Veterinary Dermatology  vol: 35  issue: 4  first page: 453  year: 2024  
doi: 10.1111/vde.13253

9. Treatment of five haemodynamically stable dogs with immune‐mediated thrombocytopenia using mycophenolate mofetil as single agent
V. K. Yau, D. Bianco
Journal of Small Animal Practice  vol: 55  issue: 6  first page: 330  year: 2014  
doi: 10.1111/jsap.12203

10. Update on Immununosuppressive Therapies for Dogs and Cats
Katrina R. Viviano
Veterinary Clinics of North America: Small Animal Practice  vol: 43  issue: 5  first page: 1149  year: 2013  
doi: 10.1016/j.cvsm.2013.04.009

11. Spontaneous autoimmune subepidermal blistering diseases in animals: a comprehensive review
Petra Bizikova, Thierry Olivry, Keith Linder, Jan Rybnicek
BMC Veterinary Research  vol: 19  issue: 1  year: 2023  
doi: 10.1186/s12917-023-03597-1